Finally, in addition to direct pro-angiogenic effects of FGFR-signaling, activation of this pathway might also mediate the activity of VEGFR-signaling and thus synergizes with VEGFR and platelet-derived growth factor receptor (PDGFR)-mediated pathways to promote tumor neo-angiogenesis [34,35]. The gene discussed is KDR; the disease is neoplasm.